Unmasking chronic granulomatous disease: A routine diagnostic workup in a Brazilian children’s hospital
Main Article Content
Keywords
immunodeficiency, chronic granulomatous disease, rhodamine 123, pediatrics, DNA sequencing
Abstract
The diagnosis of chronic granulomatous disease (CGD), a congenital immunodeficiency affecting phagocyte function, remains a challenge for patients in Latin America. It is well established that dihydrorhodamine (DHR) flow cytometry is the most commonly used screening assay; however, few pediatric immunology centers in Brazil perform this test. This study reports data from a routine diagnostic workup for CGD conducted at a Brazilian children’s hospital. A three-year prospective study was performed, enrolling children with clinical features suggestive of immunodeficiency who were screened using DHR. Sanger sequencing of the NCF1 (neutrophil cytosolic factor 1) and CYBB (cytochrome b-245, beta chain) genes was conducted in children with two consecutive abnormal DHR results. A total of 255 patients—62% males—with a median age of 3.2 years (range: 1 month–17.8 years) were evaluated. Six patients (2.4%) had abnormal DHR tests, and four of them (1.6%) received a definitive diagnosis of CGD. Most children presented with pneumonia and/or abscesses during the first year of life as the clinical manifestation of CGD. Two of the four diagnosed patients were receiving continuous antibiotics and two underwent transplantation. Pathogenic variants were identified in NCF1 (three cases) and CYBB (one case). The hospital-based diagnostic workup for CGD identified approximately one new case per 60 tested patients, indicating a high frequency of the disease in the study population. This approach may represent a valuable strategy for identifying new pediatric CGD cases in resource-limited settings.
References
2 Staudacher O, Von Bernuth H. Clinical presentation, diagnosis, and treatment of chronic granulomatous disease. Front Pediatr. 2024;12:1384550. 10.3389/fped.2024.1384550
3 Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27(1):89–99. 10.1016/j.hoc.2012.11.002
4 Robles-Marhuenda A, Álvarez-Troncoso J, Rodríguez-Pena R, Busca-Arenzana C, López-Granados E, Arnalich-Fernández F. Chronic granulomatous disease: Single-center Spanish experience. Clin Immunol. 2020;211:108323. 10.1016/j.clim.2019.108323
5 Anjani G, Vignesh P, Joshi V, Shandilya JK, Bhattarai D, Sharma J, et al. Recent advances in chronic granulomatous disease. Genes Dis. 2020;7(1):84–92. 10.1016/j.gendis.2019.07.010
6 O’Donovan CJ, Tan LT, Abidin MAZ, Roderick MR, Grammatikos A, Bernatoniene J. Diagnosis of chronic granulomatous disease: Strengths and challenges in the genomic era. J Clin Med. 2024;13(15):4435. 10.3390/jcm13154435
7 Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473–507. 10.1007/s10875-022-01289-3
8 Langer S, Radhakrishnan N, Pradhan S, Das J, Saraf A, Kotwal J. Clinical and laboratory profiles of 17 cases of chronic granulomatous disease in North India. Indian J Hematol Blood Transfus. 2021;37(1):45–51. 10.1007/s12288-020-01316-6
9 Yu JE, Azar AE, Chong HJ, Jongco AM, Prince BT. Considerations in the diagnosis of chronic granulomatous disease. J Pediatr Infect Dis Soc. 2018;7(suppl_1):S6–11. 10.1093/jpids/piy007
10 El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, et al. Role of flow cytometry in the diagnosis of chronic granulomatous disease: The Egyptian Experience. J Clin Immunol. 2016;36(6):610–8. 10.1007/s10875-016-0297-y
11 O’Gorman MR, Corrochano V. Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clin Diagn Lab Immunol. 1995;2(2):227–32. 10.1128/cdli.2.2.227-232.1995
12 Roos D, Boer M. Molecular diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2014;175(2):139–49. 10.1111/cei.12202
13 Roos D. Chronic granulomatous disease. Methods Mol Biol. 2019;1982:531–42. 10.1007/978-1-4939-9424-3_32
14 Lacerda-Pontes R, Gomes LN, Albuquerque RSD, Soeiro-Pereira PV, Condino-Neto A. The extended understanding of chronic granulomatous disease. Curr Opin Pediatr. 2019;31(6):869–73. 10.1097/MOP.0000000000000830
15 Al Kuwaiti AA, Al Dhaheri AD, Al Hassani M, Ruszczak Z, Alrustamani A, Abuhammour W, et al. Chronic granulomatous disease in the United Arab Emirates: Clinical and molecular characteristics in a single center. Front Immunol. 2023;14:1228161. 10.3389/fimmu.2023.1228161
16 De Oliveira-Junior EB, Zurro NB, Prando C, Cabral-Marques O, Pereira PVS, Schimke LF, et al. Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American patients: First report from the LASID registry: Chronic granulomatous disease in Latin America. Pediatr Blood Cancer. 2015;62(12):2101–7. 10.1002/pbc.25674
17 Costa-Carvalho B, González-Serrano M, Espinosa-Padilla S, Segundo G. Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases. Expert Rev Clin Immunol. 2017;13(5):483–9. 10.1080/1744666X.2017.1255143
18 European Society For Immunodeficiencies: Diagnosis criteria. https://esid.org/Working-Parties/Registry-Working-Party/Diagnosis-criteria. Accessed November, 2024.
19 Golightly M. Dihydrorhodamine (DHR) flow cytometry test for chronic granulomatous disease (CGD): A simple test for routine clinical flow cytometry. ICCS e-Newsletter. https://www.cytometry.org/newsletters/eICCS-2-1/article6.php. Accessed November 10, 2023.
20 Oliveira Júnior EB, Condino Neto A. Uma nova abordagem para o estudo dos defeitos genético-moleculares da doença granulomatosa crônica e análise de suas relações genótipo-fenótipo [Master’s Thesis]. São Paulo: Instituto de Ciências Biomédicas, USP; 2010.
21 Latin Society For Immunodeficiencies: https://lasidregistry.org/lasid. Accessed: January 1, 2025.
22 Kuhns DB, Hsu AP, Sun D, Lau K, Fink D, Griffith P, et al. NCF1 (p47phox)-deficient chronic granulomatous disease: Comprehensive genetic and flow cytometric analysis. Blood Adv. 2019;3(2):136–47. 10.1182/bloodadvances.2018023184
23 Prando-Andrade C, Agudelo-Florez P, Lopez JA, Paiva MADS, Costa-Carvalho BT, Condino-Neto A. Autosomal chronic granulomatous disease: Case report and mutation analysis of two Brazilian siblings. J Pediatr (Rio J). 2004;80(5):425–8.
24 Abd Elaziz D, El Hawary R, Meshaal S, Alkady R, Lotfy S, Eldash A, et al. Chronic granulomatous disease: A cohort of 173 patients—10 years single center experience from Egypt. J Clin Immunol. 2023;43(8):1799–811. 10.1007/s10875-023-01541-4
25 Rae J, Newburger PE, Dinauer MC, Noack D, Hopkins PJ, Kuruto R, et al. X-linked chronic granulomatous disease: Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet. 1998;62(6):1320–31. 10.1086/301874